NFKB1 and neoplasm: Its antitumor effects are mainly achieved by inhibiting the activation of NF-κB, downregulating anti-apoptotic proteins, upregulating pro-apoptotic proteins, and inhibiting signaling pathways such as PI3K/Akt, thereby inducing cancer cell apoptosis and inhibiting tumor growth [55].